PPAR Research · 2013 · 17 citations · 31 references
MedicinePharmacologyPhysiologyBiochemical PharmacologyMetabolic RegulationMolecular PharmacologyBlood Pressure ManagementBlood Pressure RegulationCardiovascular PharmacologyCardiovascular PhysiologyHypertension ManagementHypertension PharmacotherapyBeta-catenin RegulationBlood PressureCellular Redox SignalingHypertension PathophysiologyLipid Profile ChangesPeroxisome Proliferator-activated Receptor Alpha (Ppar-alpha) SignalingPeroxisome Proliferator-activated Receptor Gamma AgonismRedox-sensitive Signaling Pathways
PPAR γ receptor plays an important role in oxidative stress response. Its agonists can influence vascular contractility in experimental hypertension. Our study was focused on the effects of a PPAR γ agonist pioglitazone (PIO) on blood pressure regulation, vasoactivity of vessels, and redox-sensitive signaling at the central (brainstem, BS) and peripheral (left ventricle, LV) levels in young prehypertensive rats. 5-week-old SHR were treated either with PIO (10 mg/kg/day, 2 weeks) or with saline using gastric gavage. Administration of PIO significantly slowed down blood pressure increase and improved lipid profile and aortic relaxation after insulin stimulation. A significant increase in PPAR γ expression was found only in BS, not in LV. PIO treatment did not influence NOS changes, but had tissue-dependent effect on SOD regulation and increased SOD activity, observed in LV. The treatment with PIO differentially affected also the levels of other intracellular signaling components: Akt kinase increased in the the BS, while β -catenin level was down-regulated in the BS and up-regulated in the LV. We found that the lowering of blood pressure in young SHR can be connected with insulin sensitivity of vessels and that β -catenin and SOD levels are important agents mediating PIO effects in the BS and LV.
31
Massimo Collino, Manuela Aragno, Raffaella Mastrocola et al. · European Journal of Pharmacology · 2005 · 301 citations
Medicine, Neuroscience, Pharmacology +17
APC-dependent suppression of colon carcinogenesis by PPARγ
Geoffrey D. Girnun, Wendy M. Smith, Stavit Drori et al. · Proceedings of the National Academy of Sciences · 2002 · 281 citations · Full text
Medicine, Oncology, Pharmacology +15
Tero‐Pekka Alastalo, Molong Li, Vinicio de Jesús Pérez et al. · Journal of Clinical Investigation · 2011 · 255 citations · Full text